Celltrion identify 14 antibodies that neutralise COVID-19 virus
Celltrion Group has successfully selected the most potent antibody candidates to neutralise COVID-19 virus, SARS-CoV-2. Through a partnership with the Korea Centers for Disease Control...
UPDATED: MHRA guidance on coronavirus (COVID-19)
The MHRA is producing guidance on coronavirus (COVID-19) for industry. The Medicines and Healthcare products Regulatory Agency (MHRA) is working closely with Department of Health...
Advice on ibuprofen and coronavirus (COVID-19): Commission on Human Medicines
The Commission of Human Medicines (CHM) Expert Working Group on coronavirus (COVID-19) has given its advice on ibuprofen and coronavirus (COVID-19). It concluded that there is...
Interactive tool shows the science behind COVID-19 control measures
An online tool to illustrate the effects of different COVID-19 control measures has been developed by a team of University of Cambridge researchers. The ‘lowhighcovid’...
NICE COVID-19 guidelines for cystic fibrosis, COPD and dermatological conditions
NICE has published three more rapid guidelines on the care of patients with suspected and confirmed COVID-19, and in patients without COVID-19. They cover...
Industry responds to call to roll out coronavirus tests
The UK’s top pharmaceutical and diagnostic companies are teaming up to rapidly develop and roll out millions of coronavirus tests in the coming months...
Private hospital merger to be approved if local concerns addressed
The CMA has found that the completed private hospital merger between Circle and BMI does not raise UK-wide competition concerns but could reduce competition...
Cancer Research UK to cut funding by £44m
Cancer Research UK has announced that it has taken the difficult decision to cut funding to its existing grants and institutes by up to...
New vaccine platform used to develop COVID-19 vaccine candidates
UK biotech Imophoron has produced multiple COVID-19 vaccine candidates, based on its novel vaccine platform (ADDomer©), within weeks of the virus sequence being made...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...